MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid. - Wikidata - awgldk - TriplyDB

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.

http://www.wikidata.org/entity/Q37329995

about

Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI Does the Reporting Quality of Diagnostic Test Accuracy Studies, as Defined by STARD 2015, Affect Citation?Molecular imaging: from bench to clinic.18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer.Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.Systemic treatment in breast cancer: a primer for radiologists Preoperative staging of gallbladder carcinoma using biliary MR imaging.Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity.Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.An overview of imaging techniques for liver metastases management.Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?The role of imaging in the surveillance and diagnosis of hepatocellular cancer.Selection and Reporting of Statistical Methods to Assess Reliability of a Diagnostic Test: Conformity to Recommended Methods in a Peer-Reviewed Journal.Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.Evaluation of Transient Motion During Gadoxetic Acid-Enhanced Multiphasic Liver Magnetic Resonance Imaging Using Free-Breathing Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging.

P2860

Q27028207-34AA75C7-2C1A-4800-BAE9-8EDD79C119DD Q30375399-0CCED416-B6E6-4C82-9B59-F88D123B962D Q30420478-1DB6C229-16B7-4EF5-82C5-658391AFF8E8 Q33880479-0099A801-3381-4974-9963-9E754E5F9F4A Q35112515-AFC25324-1E3E-46F6-8EBB-2E5F1612993A Q36147405-94A8B269-B90F-4EC0-9297-A78109E1D996 Q36510679-13D85782-4C15-4210-B005-6A8AFE04CB56 Q38182536-C56232AD-F445-4174-BBF4-E584F9E71350 Q38238929-FF18992D-DFEB-41B4-86BB-678FAA4CB814 Q38250907-5AB95497-173A-4C4E-BC80-9C97175FA678 Q38594431-8C76630E-EDA5-4D98-9CF9-0FDD0DA182B2 Q38877730-A3857593-A28C-4559-A3EF-BE78916B831D Q39040960-A336CB0A-A687-44B3-8349-06D33FF7B1F8 Q42702576-AC69BA07-8706-44F1-86E2-97B893CEEF39 Q47660165-81A20ED4-C2EE-4792-9B5F-647BAE0A1D8F Q47774486-8287C914-2EBE-49C3-B60E-F794A3BA4110

P2860

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.

http://www.wikidata.org/entity/Q37329995

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@en

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@nl

type

label

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@en

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@nl

prefLabel

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@en

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@nl

P1433

Q37329995-2A095343-01BC-440F-835A-882D467BB39C

P1476

Q37329995-692A6A1D-40A0-4336-BBD4-640E3BD4A75A

P2093

Q37329995-1E95306A-68B8-4AB3-8328-3F3CBFE63251

Q37329995-241EB052-F521-43C6-AE4E-A40F435FF4ED

Q37329995-8F595BAA-E52A-4926-8B3C-B950C37914DF

Q37329995-8FB1ECD0-2310-437C-9F1B-EF240A754124

Q37329995-9870D420-944E-4C89-BEAB-CEC58C5B1F33

Q37329995-BD84B576-D1E8-45D0-88FC-0D87980E084D

Q37329995-CDBEFC1D-54C0-4624-95EF-2B1D9B2927D8

P2860

Q37329995-04B40846-5B9D-44E0-B7D4-6D9B6B949335

Q37329995-11161931-643C-4BED-94E5-5BBB598FB495

Q37329995-121C1463-6311-464E-8659-7E807E19D9B8

Q37329995-19904E9F-33A3-4FB9-8559-F1BF5945F559

Q37329995-1C7A2791-BD5E-402B-AE06-C86156EC1F5C

Q37329995-20C43E2C-4BBD-447A-BE5C-228C90FF2403

Q37329995-3BF6AAB0-A755-4CDB-9C7B-92DDC19EE890

Q37329995-3F748D4C-7613-4A5A-BAB6-AED86923733A

Q37329995-460235A1-0248-45DF-8368-A2BFF5994BF4

Q37329995-4B409D9D-FB81-4E2C-8349-A4D00FEC8A30

P304

Q37329995-ACC9309E-4114-40A2-9988-BD2EDD3A2B40

P31

Q37329995-23A1F8E0-FD5B-4EE1-9A35-8EC06C7126EC

P356

Q37329995-463FB981-4B60-4E85-A6E3-655313CBD413

P433

Q37329995-3EC725A3-0F08-47E6-9062-B6567B4A0AB6

P478

Q37329995-07F49889-D5BF-49BA-AD35-13236CCAAD17

P50

Q37329995-0A53E0E5-3316-4358-869C-66170A7335BF

Q37329995-8DFB5496-7B0C-43DF-899B-13D42E9B39A3

P577

Q37329995-722BFB6B-339F-49F1-A6A4-13C8EAA9DB88

P5875

Q37329995-E965E4F9-413D-4672-9E9D-9AA4E4EB43CC

P698

Q37329995-E589DA43-471A-4D4B-9503-80FC0707E2C1

P932

Q37329995-3A102C93-71DA-4602-80D1-E4531D0CCCE9

P356

KJR.2013.14.6.894

P1433

Korean journal of radiology : official journal of the Korean Radiological Society

P1476

MR imaging in patients with su ...... contrast agent gadoxetic acid.

@en

P2093

Byung Ihn Choi

http://www.w3.org/2001/XMLSchema#string

Hee Sun Park

http://www.w3.org/2001/XMLSchema#string

Jeong-Hee Yoon

http://www.w3.org/2001/XMLSchema#string

Ji Hoon Park

http://www.w3.org/2001/XMLSchema#string

Jung Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Kyung Hee Lee

http://www.w3.org/2001/XMLSchema#string

Mi Hye Yu

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of two data analyses from two observer performance studies using Jackknife ROC and JAFROC.

Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method.

CT and MR imaging of hepatic metastases.

Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.

Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.

Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma.

Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging

Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging

New MR techniques for the detection of liver metastases

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

P304

894-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3348/KJR.2013.14.6.894

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258830363

http://www.w3.org/2001/XMLSchema#string

P698

24265564

http://www.w3.org/2001/XMLSchema#string

P932

3835636

http://www.w3.org/2001/XMLSchema#string